Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Innate Pharma S.A.
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
January 12, 2024
From
Innate Pharma S.A.
Via
Business Wire
Tickers
IPHA
Innate Pharma Announces IPH5201 Phase 2 Study in Lung Cancer
June 03, 2022
From
Innate Pharma S.A.
Via
Business Wire
Tickers
IPHA
Outcome of Innate Pharma’s 2022 Annual General Meeting
May 20, 2022
From
Innate Pharma S.A.
Via
Business Wire
Tickers
IPHA
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2022
January 24, 2022
From
Innate Pharma S.A.
Via
Business Wire
Tickers
IPHA
Innate Pharma: Monalizumab Combined With Cetuximab and Durvalumab Demonstrates Anti-Tumor Activity in First-Line Recurrent or Metastatic Head and Neck Cancer at ESMO Immuno-Oncology 2021 Congress
December 09, 2021
From
Innate Pharma S.A.
Via
Business Wire
Tickers
IPHA
Innate Pharma Third Quarter 2021 Report
November 16, 2021
From
Innate Pharma S.A.
Via
Business Wire
Tickers
IPHA
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.